SJR Q1
Signal Transduction and Targeted Therapy
Quick take: High-impact scholarly journal with premier SCImago Q1 citation metrics.Latest SJR: 17.740 (H-Index: 224).
ISSN: 2059-3635, 2095-9907Biochemistry, Genetics & Molecular Biology
—
CORE Rank
17.740
SJR Score
Q1
SJR Quartile
224
H-Index
—
Impact Factor
SJR Metric & H-Index Progression
Data: SCImago Journal Rank (Scopus-based citation metric)Metric:
CORE / ERA Rank History
Prestige ratings over evaluation roundsNo historical CORE or ERA evaluation rounds recorded.
Historical SJR & H-Index Records
Yearly progression from SCImago| Year | SJR Score | Quartile | H-Index |
|---|---|---|---|
| 2025 | 17.740 | Q1 | 224 |
| 2024 | 12.135 | Q1 | 224 |
| 2023 | 8.737 | Q1 | 224 |
| 2022 | 6.630 | Q1 | 224 |
| 2021 | 5.157 | Q1 | 224 |
| 2020 | 4.284 | Q1 | 224 |
| 2019 | 3.755 | Q1 | 224 |
| 2018 | — | — | 224 |
| 2017 | — | — | 224 |
| 2016 | — | — | 224 |
Journal Specifications & Metadata
ISSN
2059-3635, 2095-9907
Publisher
—
Country
—
Access Model
Subscription / Hybrid
Subject Categories
Biochemistry, Genetics & Molecular Biology